While fasting glucagon was associated with cardiometabolic risk markers (e.g., BMI SDS, body fat percentage, liver fat percentage, triglycerides, blood pressure), it was not associated with hyperglycemia. The gene discussed is GCG; the disease is Hyperglycemia.